Form 4: Rapport Therapeutics Director Buys Shares
Insider Transaction (Form 4)
James Healy, a Director of Rapport Therapeutics, Inc., purchased 969,480 shares of common stock on October 28, 2026 for $21.00 per share.
Summary
- Open-market purchase: acquired 952,380 Common Stock at $21.00 ($19,999,980) on October 28, 2026; holds 2,815,707 after (Indirect).
- Open-market purchase: acquired 6,395 Common Stock at $21.00 ($134,295) on October 28, 2026; holds 17,990 after (Indirect).
- Open-market purchase: acquired 3,772 Common Stock at $21.00 ($79,212) on October 28, 2026; holds 14,924 after (Indirect).
- Open-market purchase: acquired 6,933 Common Stock at $21.00 ($145,593) on October 28, 2026; holds 25,267 after (Indirect).
Sentiment
Score: 9
Explanation: StockSavvy.ai views this as a bullish signal: an insider made an open-market purchase of $20,359,080, committing personal capital to the stock.
Insider Transactions
James Healy — Director
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-10-28 | Open-market purchase | Common Stock | 952,380 | $21 | $20.0M | 2,815,707 |
| 2026-10-28 | Open-market purchase | Common Stock | 6,395 | $21 | $134.3K | 17,990 |
| 2026-10-28 | Open-market purchase | Common Stock | 3,772 | $21 | $79.2K | 14,924 |
| 2026-10-28 | Open-market purchase | Common Stock | 6,933 | $21 | $145.6K | 25,267 |
Key Dates
| Date | Description |
|---|---|
| 2026-10-28 | Open-market purchase (952,380 shares) |
| 2026-10-28 | Open-market purchase (6,395 shares) |
| 2026-10-28 | Open-market purchase (3,772 shares) |
| 2026-10-28 | Open-market purchase (6,933 shares) |
Keywords
insider transaction, Form 4, RAPP, Rapport Therapeutics, Inc., bullish, James Healy
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.